Lymphangitis and refractory lymphedema after treatment with topical cantharidin.
Stazzone
A M
AM
Borgs
P
P
Witte
C L
CL
Witte
M H
MH
D000279:Administration, Cutaneous; D000328:Adult; D002193:Cantharidin / Q000009:adverse effects*; D002481:Cellulitis / Q000139:chemically induced; D005260:Female; D005534:Foot Diseases / Q000188:drug therapy; D006801:Humans; D007509:Irritants / Q000009:adverse effects*; D008205:Lymphangitis / Q000139:chemically induced* / Q000000981:diagnostic imaging; D008209:Lymphedema / Q000139:chemically induced* / Q000000981:diagnostic imaging; D011877:Radionuclide Imaging; D019275:Radiopharmaceuticals; D013668:Technetium Tc 99m Aggregated Albumin; D014860:Warts / Q000188:drug therapy
D007509:Irritants; D019275:Radiopharmaceuticals; D013668:Technetium Tc 99m Aggregated Albumin; D002193:Cantharidin